Executive Development Committee and Advisory Group

Executive Strategic Plan Development Committee

The Executive Strategic Plan Development Committee (ESPDC) was formed in fall 2015 to develop a new strategic plan charting the future for UC Irvine Health.

The 18-member committee oversaw the strategic planning process, and the creation of a new enterprise-wide vision statement along with aspirations to provide focus.

ESPDC Members

  • Howard Federoff, PhD, MD – Chair
  • Alpesh Amin, MD
  • Larry Anstine
  • Ruth Benca, MD, PhD
  • Rebecca Brusuelas-James
  • Steve Cesca
  • Teresa Conk
  • Dan Cooper, MD
  • Geoffrey Abbott PhD – COHS Academic Senate Chair and Professor, Physiology & Biophysics
  • Al Goldin, PhD, MD
  • Sonia Lane, RN
  • Doug Merrill, MD
  • Manny Porto, MD
  • Peter Schneider
  • Shyrl Sistrunk, MD
  • Michael Stamos, MD
  • Suzanne Sandmeyer, PhD – Senior Associate Dean, Research and Professor, Biological Chemistry

Strategic Plan Advisory Group

In addition to the ESPDC, a Strategic Plan Advisory Group, comprised of representatives from the university campus, health sciences and external organizations, was formed to review progress and provide input throughout the plan’s development.

Advisory Group Members

  • Ramona Agrela
  • Nick Anas, MD
  • Michael Arias
  • Erik Barton, MD
  • Robert Bristow, MD
  • Olivier Civelli, PhD
  • Dwight Claustre
  • Emily Dow, MD
  • Scott Engwall, MD
  • Christine Gall, PhD
  • Lisa Gibbs, MD
  • Jon Gilwee
  • Douglas M. Haynes, PhD
  • Brian Hervey
  • Frank Hsu, PhD, MD
  • Peter Kaiser, PhD
  • Jeff Lefkoff
  • Shaista Malik, PhD, MD
  • John Murray
  • Patrick Patterson
  • Chuck Podesta
  • Nilam Ramsinghani, MD
  • Steven Ross, MD
  • Steven Small, PhD, MD
  • Roger Steinert, MD
  • Bruce Tromberg, PhD
  • Mona Wapner